- Price is above Fair Value, showing premium demand versus the model.
300246
SHZ
Week ended 18 Sep 2026
Weekly Investor Report
Guangdong Biolight Meditech Co., Ltd. · Healthcare · Medical Devices
Latest close
15.72 CNY
12.8%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -2.7% below the Trend Line and sits at 56.3% of its 52-week range. The latest completed week returned 12.8%, after a 4.3% four-week move. The latest news-sentiment score is 50/100.
Setup score
50
out of 100
Latest Close
15.72 CNY
18 Sep 2026
1W Return
12.8%
latest completed week
4W Return
4.3%
short-term follow-through
12W Return
8.3%
quarterly tape
Trend Breadth
84.6%
44 of 52 weeks active
Volume Ratio
1.4x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
12.8%
Latest completed week; four-week move 4.3%.
Indicator stack
47/22
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
3 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -2.7% below the Trend Line and sits at 56.3% of its 52-week range. The latest completed week returned 12.8%, after a 4.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
21 Aug
28 Aug
4 Sep
11 Sep
18 Sep
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.4312-week average 0.59
12-week confirmation
Trend active9/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.43Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 4.3% over four weeks, 8.3% over 12 weeks, and 77.7% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year44
Trend breadth84.6%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.93Latest activity-pressure read.
Pressure change-136.1%Four-week change in activity pressure.
Leadership22.41Latest relative-leadership reading.
RS change30.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 3 relevant articles.
0 positive · 3 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-28.5%Distance below the 52-week high.
13-week volatility11.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
27 Mar
24 Apr
22 May
19 Jun
17 Jul
14 Aug
18 Sep
Weeks higher15 of 2610 weeks finished lower.
Best week+19.7%Week of 19 Jun.
Worst week-23.5%Week of 26 Jun.
Latest week+12.8%Week of 18 Sep.
Shape of recent returns
Strong gains9
Modest gains6
Flat weeks1
Modest losses5
Sharp losses5
Recent vol11.4%13-week weekly-return volatility.
Base vol10.9%52-week weekly-return volatility.
Up/down split27/22Count of positive and negative weeks in the 52-week window.
Average skew8.4% / -6.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCN Healthcare
4-week rank- / 100
Group average-4.7%
Trend breadth24.0%
Trend24.0%active weekly trend signals
MD80.0%positive activity pressure
RS33.0%positive relative leadership
Four-week leaders
IndustryCN Medical Devices
4-week rank11 / 64
Group average-2.3%
Trend breadth7.8%
Trend7.8%active weekly trend signals
MD70.3%positive activity pressure
RS18.8%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape48/100
Trend, activity pressure, participation, and risk combine to a 48/100 tape read.
Indicator analysis54/100Latest 12-week confirmation: trend 9/12, activity pressure 0/12, relative leadership 12/12.
Activity pressure 0.43; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 3 relevant articles.
Enterprise value to EBITDA forward of Guangdong Biolight Meditech Co., Ltd. Class A – SZSE:300246 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 18 Sep 2026 | 15.72 CNY | 12.8% | 16.15 CNY | 9.70 CNY | -0.93 | 22.41 | 42.3M | Off |
| 11 Sep 2026 | 13.93 CNY | -7.1% | 16.07 CNY | 9.68 CNY | -0.92 | 10.90 | 38.9M | Off |
| 4 Sep 2026 | 14.99 CNY | 0.3% | 16.06 CNY | 9.66 CNY | -0.69 | 19.76 | 46.4M | Off |
| 28 Aug 2026 | 14.95 CNY | -0.8% | 15.98 CNY | 9.63 CNY | -0.55 | 16.71 | 58.3M | On |
| 21 Aug 2026 | 15.07 CNY | -20.7% | 15.96 CNY | 9.61 CNY | -0.39 | 17.20 | 112.7M | On |
| 14 Aug 2026 | 19.00 CNY | -1.3% | 15.92 CNY | 9.59 CNY | -0.47 | 45.71 | 20.5M | On |
| 7 Aug 2026 | 19.26 CNY | 0.0% | 15.60 CNY | 9.55 CNY | -0.71 | 49.54 | 0 | On |
| 31 Jul 2026 | 19.26 CNY | 10.3% | 15.22 CNY | 9.50 CNY | -0.91 | 59.24 | 22.0M | On |
| 24 Jul 2026 | 17.46 CNY | 19.7% | 14.85 CNY | 9.46 CNY | -1.14 | 44.11 | 15.9M | On |
| 17 Jul 2026 | 14.59 CNY | -3.2% | 14.54 CNY | 9.42 CNY | -1.23 | 22.20 | 10.5M | On |
| 10 Jul 2026 | 15.07 CNY | 1.8% | 14.32 CNY | 9.40 CNY | -0.88 | 15.47 | 10.5M | On |
| 3 Jul 2026 | 14.81 CNY | 2.0% | 14.10 CNY | 9.38 CNY | -0.74 | 10.00 | 12.1M | On |
| 26 Jun 2026 | 14.52 CNY | -23.5% | 13.90 CNY | 9.36 CNY | -0.45 | 7.06 | 14.7M | On |
| 19 Jun 2026 | 18.99 CNY | 19.7% | 13.69 CNY | 9.34 CNY | 0.14 | 38.45 | 59.5M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.